Showing results (61-70 of 189) with videos related to
Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|June 25, 2015
Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel diseaseT Lobatón, M Ferrante, P Rutgeerts, et al.Human Molecular Genetics|January 26, 2006
ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approachG-T Ho, N Soranzo, E R Nimmo, et al.Alimentary Pharmacology & Therapeutics|July 18, 2006
The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohortG-T Ho, P Chiam, H Drummond, et al.Inflammatory Bowel Diseases|April 29, 1998
The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel diseaseJ Satsangi, C J Landers, K I Welsh, et al.Alimentary Pharmacology & Therapeutics|February 8, 2017
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel diseaseU Mahadevan, S Vermeire, K Lasch, et al.Research in Veterinary Science|August 31, 2010
The effect of medetomidine on the regional cerebral blood flow in dogs measured using Technetium-99m-Ethyl Cysteinate Dimer SPECTT Waelbers, K Peremans, S Vermeire, et al.Alimentary Pharmacology & Therapeutics|February 7, 2017
Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control studyS Van Steenbergen, S Bian, S Vermeire, et al.Gut|April 22, 2005
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish populationC L Noble, E R Nimmo, H Drummond, et al.Clinical and Experimental Immunology|March 1, 1987
Interleukin 1 in Crohn's diseaseJ Satsangi, R A Wolstencroft, J Cason, et al.Journal of Viral Hepatitis|May 31, 2001
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infectionG Harcourt, S Hellier, M Bunce, et al.Pageof 19